SU6656
CAS No. 330161-87-0
SU6656( SU6656 | SU 6656 | SU-6656 )
Catalog No. M17482 CAS No. 330161-87-0
SU 6656 is a selective inhibitor of Src family kinases, with IC50 of 280 nM, 20 nM, 130 nM, and 170 nM for Src, Yes, Lyn, and Fyn, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 42 | In Stock |
|
| 5MG | 69 | In Stock |
|
| 10MG | 128 | In Stock |
|
| 25MG | 255 | In Stock |
|
| 50MG | 426 | In Stock |
|
| 100MG | 632 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSU6656
-
NoteResearch use only, not for human use.
-
Brief DescriptionSU 6656 is a selective inhibitor of Src family kinases, with IC50 of 280 nM, 20 nM, 130 nM, and 170 nM for Src, Yes, Lyn, and Fyn, respectively.
-
DescriptionSU6656 is a potent and selective dual inhibitor of Src family kinases and Aurora kinase. SU6656 modulates CTGF (connective tissue growth factor) expression in an ERK-dependent manner. SU6656 induces caspase-independent cell death in FRO anaplastic thyroid carcinoma cells and therapeutic synergy in human synovial sarcoma growth, invasion and angiogenesis in vivo.
-
In Vitro——
-
In VivoAnimal Model:Swiss albino male mice Dosage:2, 4 mg/kg Administration:Intraperitoneal injection; once Result:Significantly decreased IPoCo mediated increase in fall down time.
-
SynonymsSU6656 | SU 6656 | SU-6656
-
PathwayMAPK/ERK Signaling
-
TargetRaf
-
RecptorFyn| Lyn| Src| Yes
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number330161-87-0
-
Formula Weight371.45
-
Molecular FormulaC19H21N3O3S
-
Purity>98% (HPLC)
-
SolubilityDMSO : 18.5 mg/mL. 49.80 mM;
-
SMILESCN(C)S(=O)(=O)c1cc2c(cc1)NC(=O)/C/2=C\c1cc2c([nH]1)CCCC2
-
Chemical Name(Z)-N,N-dimethyl-2-oxo-3-((4,5,6,7-tetrahydro-1H-indol-2-yl)methylene)indoline-5-sulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Blake RA, et al. Mol Cell Biol. 2000, 20(23), 9018-9027.
molnova catalog
related products
-
GSK2008607
GSK2008607 is a potent B-RafV600E inhibitor with anticancer activity and can be used to study breast, colorectal, melanoma, thyroid, and ovarian cancers.
-
BGB-283
BGB-283 (Lifirafenib, BGB283) is a potent pan RAF inhibitor of BRAF V600E, wt BRAF, CRAFY340/341D and wt ARAF (IC50=5-40 nM).
-
Effusanin A
Effusanin A has antibacterial activity. It exhibits DNA-damaging activity in assay which employed DNA-repair deficient (RAD 52Y) and repairs proficient (RAD +) yeast strains. Effusanin A shows inhibitory effects on DU145 cells with IC50 value of 3.16 μM, and LoVo cells with IC50 value of 3.02 μM.
Cart
sales@molnova.com